F118 Psoriasis and Atopic Dermatitis: Advances in Comorbidities and Therapy
DESCRIPTION
Psoriasis and atopic dermatitis are common, immune-mediated chronic diseases that have emerging therapeutic options (topical, oral, biologic, biosimilar). We will discuss newly approved therapies as well as therapies that will be approved in the near future. We will compare and contrast comorbidities of these two conditions.
LEARNING OBJECTIVES
Evaluate recent data of comorbidities in psoriasis and atopic dermatitis.
Discuss emerging therapies for psoriasis and atopic dermatitis.
SCHEDULE
3:30 PM
Welcome and introduction
Jashin J. Wu, MD, FAAD
3:31 PM
Atopic dermatitis: comorbidities
Katrina Abuabara, MD, FAAD
3:55 PM
Atopic dermatitis: therapy
Amy S. Paller, MD, FAAD
4:20 PM
Psoriasis: new and emerging biologics
Kenneth B. Gordon, MD, FAAD
4:40 PM
Psoriasis: comorbidities
Julia-Tatjana Maul, MD
5:05 PM
Psoriasis: new and emerging topical and oral therapies
Jashin J. Wu, MD, FAAD
DIRECTOR
Jashin J. Wu, MD, FAAD
SPEAKERS
Katrina Abuabara, MD, FAAD
Kenneth B. Gordon, MD, FAAD
Julia-Tatjana Maul, MD
Amy S. Paller, MD, FAAD
HANDOUTS
DISCLOSURES
Katrina Abuabara, MD, FAAD
Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Fees); Cedar Healthcare – Stockholder(Stock); Eli Lilly – Advisory Board(Honoraria); Incyte – Consultant (1099 relationship)(Fees); Medidata – Consultant (1099 relationship)(Fees); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); TARGET Pharma – Advisory Board(Fees);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Julia-Tatjana Maul, MD
No financial relationships exist with ineligible companies.
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Jashin J. Wu, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Aristea Therapeutics – Consultant(Honoraria); Bausch Health – Consultant(Honoraria), Speaker(Honoraria); Bayer – Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Codex Labs – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); DermTech Inc. – Consultant(Honoraria); Dr Reddy's Laboratory – Consultant(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); EPI Health – Consultant(Honoraria); Galderma – Speaker(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria); Incyte – Investigator(Grants/Research Funding); Janssen Biotech – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Mindera – Consultant(Honoraria); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Regeneron – Consultant(Honoraria), Speaker(Honoraria); Samsung Bioepis – Consultant(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Solius – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria), Speaker(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria); Zerigo Health – Consultant(Honoraria);